In recent trading, GoodRx Holdings Inc. (NASDAQ: GDRX) shares rose to $3.80, surpassing the average 12-month analyst target price of $3.73. This movement prompts analysts to reconsider their expectations—either downgrading their valuation or raising their price targets based on the company’s performance.
Currently, 14 analysts cover GoodRx, with target prices ranging from $2.50 to $5.00, reflecting a standard deviation of $0.899. The consensus rating for the stock is 2.63, categorized from 1 (Strong Buy) to 5 (Strong Sell). Breakdown of ratings shows 4 Strong Buy, 1 Buy, 9 Hold, 1 Sell, and 1 Strong Sell.
Investors are encouraged to evaluate whether the recent price surge indicates further growth potential or if the valuation might be stretched, warranting a reassessment of their positions.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
